Research News

---

Topic: Targeted Therapies (view all topics)

Tags for topic Targeted Therapies:

• Adjuvant
• Afinitor
• Avastin
• Herceptin
• Iniparib
• Neoadjuvant
• Perjeta (chemical name: pertuzumab; aka Omnitarg)
• T-DM1
• Tykerb

View articles by month and year

• Afinitor Approved to Treat Advanced-Stage, Hormone-Receptor-Positive Disease

  Published on July 24, 2012 at 12:00 am

  • Tags: Afinitor

  Afinitor has been approved to be used in combination with Aromasin to treat advanced-stage, hormone-receptor-positive, HER2-negative breast cancer in postmenopausal women that has already been treated with Femara or Arimidex.

• Afinitor Before Surgery Doesn’t Help Treat HER2-Negative Breast Cancer

  Published on December 11, 2011 at 12:00 am

  • Tags: Abraxane (chemical name: paclitaxel), Cytoxan (chemical name: cyclophosphamide), Ellence (chemical name: epirubicin), Taxol (chemical name: paclitaxel), Standard, Neoadjuvant, Afinitor, Avastin, and Neoadjuvant

  Research has found that adding Afinitor to paclitaxel didn't improve the response to neoadjuvant treatment with paclitaxel in women diagnosed with advanced-stage, HER2-negative breast cancer.

• Afinitor Helps Slow Growth of Certain Advanced-Stage Breast Cancers

  Published on December 7, 2011 at 12:00 am

  • Tags: Afinitor

  New information from the BOLERO-2 study shows that women diagnosed with hormone-receptor-positive, HER2-negative advanced-stage or metastatic breast cancer who got Afinitor and Aromasin in combination lived more than twice as long without the cancer growing than women who got only Aromasin.

• Afinitor Added to Aromasin Slows Advanced-Stage Breast Cancer Growth

  Published on September 25, 2011 at 12:00 am

  • Tags: Afinitor

  A study showed that postmenopausal women with advanced breast cancer who took Afinitor (chemical name: everolimus) with the aromatase inhibitor Aromasin (chemical name: exemestane) appeared to have longer progression-free survival compared to women taking Aromasin with a placebo.

• Afinitor Study Stopped Early Because of Good Results

  Published on July 5, 2011 at 12:00 am

  • Tags: Afinitor

  A study looking at the benefits of Afinitor to treat certain advanced-stage and metastatic breast cancers was stopped early because of good results.

• Afinitor May Make Metastatic Breast Cancer Start Responding to Other Medicines Again

  Published on June 7, 2010 at 12:00 am

  • Tags: Herceptin and Afinitor

  A small, early study suggests that Afinitor, a targeted therapy medicine, can make HER2-positive, metastatic breast cancers that have stopped responding to Herceptin and Taxol start responding to those treatments again.

• Experimental Combo Shows Promise for Treating Metastatic HER2-Positive Cancer

  Published on June 6, 2010 at 12:00 am

  • Tags: Herceptin and Afinitor

  A very small, very early study suggests that a combination of Herceptin and Afinitor may help treat HER2-positive, metastatic breast cancers that have stopped responding to many other treatments.